Sign in

CIK 0001936258 · Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. EFFECT Other Notice of Effectiveness
  4. 424B3 Offering Prospectus
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. UPLOAD Other SEC-generated Letter
  7. F-3 Offering F-3
  8. 424B3 Offering Prospectus
  9. 6-K Event Report of Foreign Issuer
  10. 6-K Event Report of Foreign Issuer
  11. 6-K Event Report of Foreign Issuer
  12. 424B3 Offering Prospectus
  13. 6-K Event Report of Foreign Issuer
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 6-K Event Report of Foreign Issuer
  16. 424B3 Offering Prospectus
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 6-K Event Report of Foreign Issuer
  19. EFFECT Other Notice of Effectiveness
  20. POS AM Other Post-effective Amendment for Registration Statement

Page 16 of 21 · 415 filings